AU4193289A - Retroviral vectors expressing soluble cd4: a gene therapy for aids - Google Patents

Retroviral vectors expressing soluble cd4: a gene therapy for aids

Info

Publication number
AU4193289A
AU4193289A AU41932/89A AU4193289A AU4193289A AU 4193289 A AU4193289 A AU 4193289A AU 41932/89 A AU41932/89 A AU 41932/89A AU 4193289 A AU4193289 A AU 4193289A AU 4193289 A AU4193289 A AU 4193289A
Authority
AU
Australia
Prior art keywords
aids
gene therapy
retroviral vectors
vectors expressing
expressing soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU41932/89A
Other versions
AU647013B2 (en
Inventor
W. French Anderson
Robert C. Gallo
Richard A. Morgan
Daryl Muenchau
Flossie Wong-Staal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce filed Critical US Department of Commerce
Publication of AU4193289A publication Critical patent/AU4193289A/en
Application granted granted Critical
Publication of AU647013B2 publication Critical patent/AU647013B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70514CD4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU41932/89A 1988-08-22 1989-08-21 Retroviral vectors expressing soluble CD4: a gene therapy for aids Ceased AU647013B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23464688A 1988-08-22 1988-08-22
US234646 1988-08-22
US39545489A 1989-08-18 1989-08-18
US395454 1989-08-18

Publications (2)

Publication Number Publication Date
AU4193289A true AU4193289A (en) 1990-03-23
AU647013B2 AU647013B2 (en) 1994-03-17

Family

ID=26928158

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41932/89A Ceased AU647013B2 (en) 1988-08-22 1989-08-21 Retroviral vectors expressing soluble CD4: a gene therapy for aids

Country Status (4)

Country Link
EP (1) EP0431045A4 (en)
JP (1) JPH03505039A (en)
AU (1) AU647013B2 (en)
WO (1) WO1990001870A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1038306A (en) * 1988-03-21 1989-12-27 维吉恩公司 Recombinant retroviruses
US5716826A (en) * 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
ATE219519T1 (en) * 1989-01-23 2002-07-15 Chiron Corp RECOMBINANT THERAPIES FOR INFECTIONS AND HYPERPROLIFERATIVE DISORDERS
US6251675B1 (en) 1989-05-25 2001-06-26 Duke University Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication
US5871958A (en) * 1989-05-25 1999-02-16 Duke University Mutant rev genes encoding transdominant repressors of HIV replication
WO1995004824A1 (en) * 1993-08-05 1995-02-16 Medvet Science Pty. Ltd. Generation of dna libraries and retroviral vectors for same
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
EP1088892A1 (en) * 1999-09-24 2001-04-04 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
US6479280B1 (en) * 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
DE10063111A1 (en) * 2000-12-18 2002-06-20 Bayer Ag Replication assay for the detection of antiviral substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2559159B1 (en) * 1984-02-02 1986-09-12 Inst Nat Sante Rech Med VIRAL VECTORS FOR THE CLONING AND EXPRESSION OF A PROTEIN IN A EUKARYOTIC CELL, COMPRISING AT LEAST ONE PART OF THE GENOME OF A RETROVIRUS; TRANSFECTED EUKARYOTIC CELLS; PROCESS USING SUCH CELLS AND PROTEINS OBTAINED
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
ATE135747T1 (en) * 1986-08-21 1996-04-15 Univ Columbia DNA ENCODING THE T-CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS

Also Published As

Publication number Publication date
EP0431045A4 (en) 1991-10-30
AU647013B2 (en) 1994-03-17
EP0431045A1 (en) 1991-06-12
WO1990001870A1 (en) 1990-03-08
JPH03505039A (en) 1991-11-07

Similar Documents

Publication Publication Date Title
AU3941689A (en) Herbicidal aryloxy benzotriazoles and processes for their preparation
AU4210489A (en) Herbicidal triazolinones
AU1540388A (en) Yeast vector
AU4271789A (en) Battery charger
AU2051988A (en) Energy polymerizable polyurethane precursors
AU1359788A (en) New substituted Triazolinones
AU1662088A (en) A ball-and-socket joint
AU8317587A (en) Therapeutic preparations
AU3795389A (en) Process for preparing highly active water-dispersible pesticides
AU2744988A (en) Heterocyclic-alkylene quinoxalinyloxyphenoxypropanoate herbicides
AU2099088A (en) Cordless telephone system
AU4193289A (en) Retroviral vectors expressing soluble cd4: a gene therapy for aids
AU1614688A (en) A phosphinothricin-resistance gene
AU2147888A (en) Water-hardening polymer preparations
AU615846B2 (en) Continuous excavating apparatus
AU3981989A (en) Improved eyedrop dispenser
AU1414688A (en) Easy-open pouch
AU1796888A (en) Bread making machine
AU1574188A (en) T-cell membrane protein
AU1532688A (en) Non-settling foams
AU3442589A (en) A mobile weighing system
AU1474988A (en) Aniline-resorcin-formaldehyde copolycondensation product
AU1799788A (en) A mill
AU1080188A (en) A cushion
AU1605588A (en) Diarylalkyl-substituted alkylamines, a process for their preparation, their use, and medicaments containing them